Cormedix
Clinical trials sponsored by Cormedix, explained in plain language.
-
New hope for kids on dialysis: drug aims to stop deadly bloodstream infections
Disease control Recruiting nowThis study tests a drug called DefenCath to see if it can prevent catheter-related bloodstream infections in children (birth to under 18) with kidney failure who are on dialysis. About 36 kids will get either DefenCath or the standard infection-prevention treatment. The goal is t…
Phase: PHASE4 • Sponsor: CorMedix • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New drug aims to cut deadly infections in patients on home IV nutrition
Disease control Recruiting nowThis study tests whether a drug called DefenCath can prevent serious bloodstream infections in adults who receive nutrition through a central line at home. About 200 participants will be randomly assigned to receive either DefenCath or a standard heparin solution as a catheter lo…
Phase: PHASE3 • Sponsor: CorMedix • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
New program offers Infection-Fighting catheter lock to patients who Can't join trials
Prevention AVAILABLEThis expanded access program provides DefenCath, a catheter lock solution, to both adults and children who need a catheter for serious medical conditions. The goal is to prevent central line-associated bloodstream infections (CLABSIs) in patients who cannot join ongoing clinical …
Sponsor: CorMedix • Aim: Prevention
Last updated May 26, 2026 09:32 UTC